The invention discloses a pharmaceutical composition for treating humid heat and blood stasis type pelvic inflammation. The pharmaceutical composition is composed of the following raw materials: 25-30 parts of salvia miltiorrhiza, 12-16 parts of red paeony roots, 14-20 parts of fructus forsythia, 12-18 parts of spina gleditsiae, 28-32 parts of sargentgloryvine stems, 16-20 parts of patrinia, 10-15 parts of processed myrrh, 10-15 parts of processed frankincense, 15-20 parts of corydalis tuber processed with vinegar, 10-14 parts of dried body of ground beetle, 28-32 parts of stir-baked rhizoma dioscoreae, 28-35 parts of semen coicis, 10-14 parts of angelica sinensis, 28-33 parts of teasel roots, 25-30 parts of astragali radix and 10-15 parts of garden balsam stem. According to the pharmaceutical composition disclosed by the invention, the selected medicinal materials are appropriate in compatibility, the formula is refined, the methods for tonifying qi, warming meridians, activating yang, promoting blood circulation to remove blood stasis and dredging collaterals are used, and clysis drug delivery is adopted, so that the drug can directly reach the lesion, pelvic blood supply is improved, and absorption of inflammatory exudation and release of adhesive tissues can be promoted. Therefore, the disease is rapidly improved, and the pharmaceutical composition is worthy of clinical popularization and application.